Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$859M |
| 2 |
Progressive
PGR
|
$429M |
| 3 |
Netflix
NFLX
|
$368M |
| 4 |
Danaher
DHR
|
$364M |
| 5 |
Adobe
ADBE
|
$343M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$710M |
| 2 |
Microsoft
MSFT
|
$619M |
| 3 |
NVIDIA
NVDA
|
$447M |
| 4 |
Eli Lilly
LLY
|
$391M |
| 5 |
AbbVie
ABBV
|
$373M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.04% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Schwab US Large- Cap ETF
SCHX
$59.2B
| $188M | 0.12% |
10,767,582
-242,373
| -2% | -$4.23M |
|
177
Amicus Therapeutics
FOLD
$2.46B
| $187M | 0.12% |
14,923,588
+1,313,153
| +10% | +$16.5M |
|
178
Sensient Technologies
SXT
$4.79B
| $184M | 0.11% |
2,592,266
-12,000
| -0.5% | -$854K |
|
179
Constellium
CSTM
$2.04B
| $183M | 0.11% |
10,649,062
-682
| -0% | -$11.7K |
|
180
OSI Systems
OSIS
$3.93B
| $183M | 0.11% |
1,553,717
-195,613
| -11% | -$23M |
|
181
Dollar Tree
DLTR
$20.6B
| $182M | 0.11% |
1,268,942
+258,809
| +26% | +$37.1M |
|
182
Core & Main
CNM
$12.7B
| $181M | 0.11% |
5,764,284
-2,080,354
| -27% | -$65.2M |
|
183
Autodesk
ADSK
$69.5B
| $180M | 0.11% |
880,446
+2,628
| +0.3% | +$538K |
|
184
Neurocrine Biosciences
NBIX
$14.3B
| $180M | 0.11% |
1,908,844
-85,677
| -4% | -$8.08M |
|
185
EOG Resources
EOG
$64.4B
| $180M | 0.11% |
1,572,083
-813,554
| -34% | -$93.1M |
|
186
Apollo Global Management
APO
$75.3B
| $179M | 0.11% |
2,333,189
-127,850
| -5% | -$9.82M |
|
187
DexCom
DXCM
$31.6B
| $178M | 0.11% |
1,381,939
+608,423
| +79% | +$78.2M |
|
188
Alight
ALIT
$2B
| $172M | 0.11% |
18,587,550
+1,128,941
| +6% | +$10.4M |
|
189
Walker & Dunlop
WD
$2.98B
| $167M | 0.1% |
2,111,361
+76,787
| +4% | +$6.07M |
|
190
Xylem
XYL
$34.2B
| $164M | 0.1% |
1,459,202
+56,958
| +4% | +$6.41M |
|
191
AstraZeneca
AZN
$253B
| $164M | 0.1% |
2,285,831
-389,584
| -15% | -$27.9M |
|
192
STAG Industrial
STAG
$6.9B
| $164M | 0.1% |
4,559,218
-739,712
| -14% | -$26.5M |
|
193
Apellis Pharmaceuticals
APLS
$3.55B
| $162M | 0.1% |
1,776,905
-2,904,577
| -62% | -$265M |
|
194
PNC Financial Services
PNC
$80.5B
| $162M | 0.1% |
1,283,196
+1,222,230
| +2,005% | +$154M |
|
195
Euronet Worldwide
EEFT
$3.74B
| $161M | 0.1% |
1,375,792
-851
| -0.1% | -$99.9K |
|
196
Cencora
COR
$56.7B
| $161M | 0.1% |
837,975
-53,568
| -6% | -$10.3M |
|
197
Cimpress
CMPR
$1.54B
| $159M | 0.1% |
2,678,553
+22,618
| +0.9% | +$1.35M |
|
198
Ambev
ABEV
$34.8B
| $158M | 0.1% |
49,858,560
+29,000
| +0.1% | +$92.1K |
|
199
Waters Corp
WAT
$18.2B
| $155M | 0.1% |
580,481
+197,600
| +52% | +$52.7M |
|
200
Aptiv
APTV
$17.5B
| $153M | 0.1% |
1,499,629
+204,467
| +16% | +$20.9M |
|